Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen

(2017) E. Quant et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial

(2011) J. P. Durand et al.   ANNALS OF ONCOLOGY

Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients

(2011) Hong-Hee Won et al.   CANCER

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

(2011) Daniel G. Haller et al.   JOURNAL OF CLINICAL ONCOLOGY

Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study

(2011) Ya-Hsu Yang et al.   SUPPORTIVE CARE IN CANCER

Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms

(2010) Luiz F. Ferrari et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

(2010) Axel Grothey et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies

(2009) R. K. Ramanathan et al.   ANNALS OF ONCOLOGY

Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study

(2009) N. Attal et al.   PAIN